MOSCOW (Sputnik) - The shelf life of Russia-developed Sputnik V vaccine against coronavirus has been extended to 18 months, according to the state register of. 03.10.2022, Sputnik International
Russias Gamaleya Research Center for Epidemiology and Microbiology intends to launch the preclinical trials of its coronavirus vaccine based on the messenger ribonucleic acid (mRNA) technology by the end of 2022, the centers deputy director, Denis Logunov, said on Thursday.On Wednesday, he said th ..
More than 150 million doses of the Sputnik V vaccine, developed by Russias Gamaleya Research Center, have already been distributed around the world, including in the home country, the centers deputy director, Denis Logunov, said on Wednesday.To date, based on a huge pool of data, more than 150 mi ..